Publication | Open Access

Treatment with phosphodiesterase inhibitors type III and V: milrinone and sildenafil is an effective combination during thromboxane-induced acute pulmonary hypertension

Molecular PharmacologyHypertensionThrombosisPulmonary Arterial HypertensionCardiovascular DiseaseMedicineAntihypertensive TherapyPhosphodiesterase InhibitorsCardiovascular PharmacologyPulmonary HypertensionPharmacotherapyPublic HealthPlatelet AntagonistPharmacologyEffective CombinationCardiologyPulmonary Vascular DiseaseAnesthesiology